Full Text View
Tabular View
No Study Results Posted
Related Studies
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
This study has been terminated.
( Based on futility analysis showing <30% chance of meeting primary endpoint. )
First Received: August 16, 2004   Last Updated: November 3, 2008   History of Changes
Sponsor: Cell Genesys
Information provided by: Cell Genesys
ClinicalTrials.gov Identifier: NCT00089856
  Purpose

The purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no longer respond to hormone therapy, who have documented metastases, and who have not been treated with chemotherapy in the past.


Condition Intervention Phase
Prostate Cancer
Biological: Immunotherapy with allogeneic prostate vaccine
Drug: Chemotherapy (Taxotere and prednisone)
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Phase III Randomized, Open-Label Study of CG1940 and CG8711 Versus Docetaxel and Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer Who Are Chemotherapy-Naïve

Resource links provided by NLM:


Further study details as provided by Cell Genesys:

Primary Outcome Measures:
  • Survival [ Time Frame: 0 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Bone pain and bone related events [ Time Frame: 0 ] [ Designated as safety issue: No ]

Enrollment: 626
Study Start Date: July 2004
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
2
Standard of care - chemotherapy
Drug: Chemotherapy (Taxotere and prednisone)
Chemotherapy (Taxotere and prednisone)
1: Experimental
Immunotherapy
Biological: Immunotherapy with allogeneic prostate vaccine
Immunotherapy with allogeneic prostate vaccine

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Confirmed diagnosis of or clinical history consistent with adenocarcinoma of the prostate
  • Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy
  • Detectable metastases
  • Any Gleason score
  • ECOG performance status 0-2

Exclusion Criteria:

  • Prior treatment with chemotherapy
  • Prior Immunotherapy
  • Prior treatment with gene therapy
  • Significant cancer related pain
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00089856

  Hide Study Locations
Locations
United States, Alabama
Central Alabama Oncology, LLC
Alabaster, Alabama, United States, 35007
United States, Alaska
Alaska Clinical Research Center
Anchorage, Alaska, United States, 99508
United States, Arizona
Palo Verde Hematology/Oncology
Glendale, Arizona, United States, 85304
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States, 85259
ACRC/Arizona Clinical Res. Ctr. Inc.
Tuscon, Arizona, United States, 85715
United States, Arkansas
Arkansas Cancer Research Center
Little Rock, Arkansas, United States, 72205
United States, California
Sharp Healthcare
San Diego, California, United States, 92123
California Pacific Medical Center
San Francisco, California, United States, 94115
Pacific Coast Hem Onc. Medical Group
Fountain Valley, California, United States, 92708
Cancer Research & Prevention Center
Soquel, California, United States, 95073
California Cancer Care
Greenbrae, California, United States, 94904
Oncology Care Medical Associates
Montebello, California, United States, 90640
San Diego Cancer Center
Vista, California, United States, 92081
Center for Urological Research
La Mesa, California, United States, 91942
Compassionate Cancer Care Medical Group, Inc.
Corona, California, United States, 92882
UC Irvine Medical Center
Orange, California, United States, 92868
San Bernardino Urological Associates
San Bernardino, California, United States, 92404
United States, Colorado
Cancer Center of Colorado Springs
Colorado Springs, Colorado, United States, 80907
Univ. of Colorado Health Science Center
Aurora, Colorado, United States, 80045
United States, Connecticut
Urology Center of Grove Hill
New Britain, Connecticut, United States, 06052-1395
Carl & Dorothy Bennett Cancer Center
Stamford, Connecticut, United States, 06902
The Hope Clinic
Bristol, Connecticut, United States, 06010
United States, Florida
Cancer Centers of Florida
Ocoee, Florida, United States, 34761
Hematology Oncology Associates of the Treasure Coast
Port St. Lucie, Florida, United States, 34952
Urology Consultants
Safety Harbor, Florida, United States, 34695
Michael and Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital
Fort Lauderdale, Florida, United States, 33308
Boca Raton Community Hospital, Inc.
Boca Raton, Florida, United States, 33486
Integrated Community Oncology Network
Jacksonville, Florida, United States, 32256
Oncology-Hematology Group of South Florida/Advanced Medical Specialists
Miami, Florida, United States, 33176
United States, Georgia
Central Georgia Cancer Care, P.C.
Macon, Georgia, United States, 31201
Georgia Cancer Specialists
Atlanta, Georgia, United States, 30084
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States, 30322
Peachtree Hematology Oncology Consultants, PC
Atlanta, Georgia, United States, 30309
Atlanta VAMC
Atlanta, Georgia, United States, 30033
United States, Hawaii
Straub Clinic & Hospital
Honolulu, Hawaii, United States, 96813
United States, Illinois
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
United States, Indiana
Welborn Clinic Research Center
Evansville, Indiana, United States, 47713
Fort Wayne Medical Oncology/Hematology Inc.
Fort Wayne, Indiana, United States, 46815
United States, Louisiana
Louisiana Oncology Associates
Lafayette, Louisiana, United States, 70506
United States, Maryland
Frederick Memorial Hospital Regional Cancer Therapy Center
Frederick, Maryland, United States, 21701
Johns Hopkins University
Baltimore, Maryland, United States, 21231
United States, Michigan
William Beaumont Hospital, Cancer Clinical Trials Office
Royal Oak, Michigan, United States, 48073-6706
West Michigan Regional Cancer and Blood Center
Free Soil, Michigan, United States, 49411
Newland Medical Associates, P.C.
Southfield, Michigan, United States, 48075
United States, Missouri
Hematology Oncology Consultants, Inc.
St. Louis, Missouri, United States, 63136
United States, Montana
Hematology/Oncology Centers of the Northern Rockies, P.C.
Billings, Montana, United States, 59101
Deaconess Billings Clinic
Billings, Montana, United States, 59101
United States, Nebraska
Omaha VA Medical Center
Omaha, Nebraska, United States, 68198-7680
Omaha VA Medical Center
Omaha, Nebraska, United States, 68105
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
United States, New Jersey
Hematology-Oncology Associates of Northern New Jersey
Morristown, New Jersey, United States, 07962
Summit Medical Group/Overlook Oncology Center
Summit, New Jersey, United States, 07901
The Center for Cancer & Hematologic Disease
Cherry Hill, New Jersey, United States, 08003
United States, New York
SUNY Upstate Medical University
Syracuse, New York, United States, 13210
Jacobi Medical Center
Bronx, New York, United States, 10461
Columbia University Medical Center
New York, New York, United States, 10032
United States, North Carolina
Northwestern Carolina Hematology Oncology, PA
Hickory, North Carolina, United States, 28602
Presbyterian Hospital/ Center for Cancer Research
Charlotte, North Carolina, United States, 28204
United States, North Dakota
Medcenter One Cancer Care / Odyssey Research
Bismarck, North Dakota, United States, 58501
Dakota Cancer Institute
Fargo, North Dakota, United States, 58103
United States, Ohio
Gabrail Cancer Center
Canton, Ohio, United States, 44718
Cleveland Clinic Foundation, Taussig Cancer Center
Cleveland, Ohio, United States, 44195
United States, Oklahoma
University of Oklahoma
Oklahoma City, Oklahoma, United States, 73104
United States, Oregon
Providence Portland Medical Center
Portland, Oregon, United States, 97213
United States, Pennsylvania
Medical Oncology Associates
Kingston, Pennsylvania, United States, 18704
Urological Associates of Lancaster
Lancaster, Pennsylvania, United States, 17604
University of Pittsburgh Cancer Center
Pittsburgh, Pennsylvania, United States, 15232
Lancaster Cancer Center, Ltd
Lancaster, Pennsylvania, United States, 17601
Urologic Surgery PC
Bala Cynwyd, Pennsylvania, United States, 19004
United States, South Carolina
Charleston Hematology Oncology
Charleston, South Carolina, United States, 29403
United States, Tennessee
The West Clinic
Memphis, Tennessee, United States, 38120
Memorial Health Care System
Chattanooga, Tennessee, United States, 37404
United States, Texas
Mary Crowley Medical Research Center
Dallas, Texas, United States, 75201
Tyler Cancer Center
Tyler, Texas, United States, 75702
Urology Specialists and Associates, P.A.
Dallas, Texas, United States, 75231
Mobley Research Center
Houston, Texas, United States, 77024
Urology San Antonio
San Antonio, Texas, United States, 78229
The Don and Sybil Harrington Cancer Center
Amarillo, Texas, United States, 79106
Center for Oncology Research and Treatment PA
Dallas, Texas, United States, 75230
Urology San Antonio
San Antonio, Texas, United States, 78229
United States, Vermont
Southwestern Oncology Research Department
Bennington, Vermont, United States, 05201
United States, Virginia
Virginia Oncology Associates
Norfolk, Virginia, United States, 23502
United States, Washington
Virginia Mason Medical Center Urology
Seattle, Washington, United States, 98101
Seattle Cancer Care Alliance
Seattle, Washington, United States, 98109
Belgium
Virga Jesse Ziekenhuis
Hasselt, Belgium, B-3500
AZ Groeninge
Kortrijk, Belgium, B-8500
ZNA Middelheim
Antwerp, Belgium, B-2020
Regionaal Ziekenhuis Sint Trudo
Sint-Truiden, Belgium, B-3800
Heilig Hartziekenhuis Roeselare Men
Roeselare, Belgium, B-8800
University Hospital Antwerp (UZA)
Edegem, Belgium, 2650
Imelda Ziekenhuis
Bonheiden, Belgium, 2820
UZ Gent
Gent, Belgium, 9000
Unversity Hospial Gent
Gent, Belgium, B-9000
Canada, Ontario
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
Canada, Quebec
CHUM Notre-Dam
Montreal, Quebec, Canada, H2L 4M1
McGill University
Montreal, Quebec, Canada, H2W1S6
Ultra Med Inc.
Pointe-Claire, Quebec, Canada, H9R 4S3
Centre Hopitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4
France
Centre Alexis Vautrin
Vandoeuvre les Nancy Cedex, France, 54511
Centre Francois Baclesse
Caen Cedex 5, France, 14076
Institut Jean Godinot
Reims Cedex, France, 51056
Centre Paul Papin
Angers Cedex, France, 49033
Centre Georges Francois Leclerc
Dijon Cedex, France, 77980
Centre Rene Gauducheau
Nantes-Saint Herblain, France, 44805
Institut Paoli-Calmettes
Marseille, France, 13009
Centre Leon Berard Service de Cancerologie Medicale
Lyon Cedex, France, 08
Germany
Universitatsklinik um Essen
Essen, Germany, 45122
der Technischen Universitat Dresden
Dresden, Germany, 1307
Universitatsklinik um des Saarlande
Homburg/Saar, Germany, 66421
Universitatsklinikum Aachen Urologie
Aachen, Germany, 52074
Netherlands
University Medical Centre Groningen
Groningen, Netherlands
VU Medisch Centrum
Amsterdam, Netherlands, 1081 HV
Sweden
Akademiska University Hospital
Uppsala, Sweden, 85
University Hospital Lund
Lund, Sweden
University Hospital, Linkoping
Linkoping, Sweden
United Kingdom
Beatson Oncology Centre
Glasgow, United Kingdom, G11 6NT
St. James's University Hospital
Leeds, United Kingdom, LS97TF
Newcastle General Hospital
Newcastle upon Tyne, United Kingdom, NE4 6BE
Royal Hallamshire Hospital
Sheffield, United Kingdom, S10 2JF
Scunthorpe General Hospital
Scunthorpe, United Kingdom, DN15 7BH
Hammersmith Hospital
London, United Kingdom, W12 0NN
Oxford Cancer Centre, Churchill Hospital
Oxford, United Kingdom, OX3 7LT
Addenbrooke's Hospital
Cambridge, United Kingdom, CB2 2QQ
Mount Vernon Hospital
Middlesex, United Kingdom, HA6 2RN
Glan Clwyd Hospital
Wales, United Kingdom, LL18 5UJ
Northampton General Hosptial
Northampton, United Kingdom, NN1 5BD
Nottingham City Hospital
Nottingham, United Kingdom, NG5 1PB
Sponsors and Collaborators
Cell Genesys
  More Information

No publications provided

Responsible Party: Cell Genesys, Inc. ( Cell Genesys, Inc )
Study ID Numbers: G-0029, (VITAL-1)
Study First Received: August 16, 2004
Last Updated: November 3, 2008
ClinicalTrials.gov Identifier: NCT00089856     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Cell Genesys:
Prostate
Cancer
Metastatic
Hormone-refractory
GVAX
Chemotherapy
Taxotere
Docetaxel
Prednisone
Vaccine
Allogeneic cells
Advanced Prostate Cancer

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Prednisone
Antineoplastic Agents, Hormonal
Genital Neoplasms, Male
Prostatic Diseases
Antineoplastic Agents
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Urogenital Neoplasms
Genital Diseases, Male
Glucocorticoids
Hormones
Pharmacologic Actions
Docetaxel
Neoplasms
Neoplasms by Site
Therapeutic Uses
Prostatic Neoplasms

ClinicalTrials.gov processed this record on November 27, 2009